Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 405-420 , September 2008

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

  • Helen E. Heslop, MBChB, MD (Professor of Medicine and Pediatrics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Center for Cell and Gene Therapy, 1102 Bates St, Suite 1120, Houston, TX 77030, USA. Tel.: +1 832 824 4662; Fax: +1 832 825 4668.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00053-4

doi: 10.1016/j.beha.2008.06.002

Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 405-420 , September 2008

Article Tools

* Image Usage & Resolution